Success of blood test for autism affirmed
One year after researchers published their work on a physiological test for autism, a follow-up study confirms its exceptional success in assessing whether a child is on the autism spectrum. A physiological test that supports a clinician’s diagnostic process has the potential to lower the age at which children are diagnosed, leading to earlier treatment. Results of the study, which uses an algorithm to predict if a child has autism spectrum disorder (ASD) based on metabolites in a blood sample, published online today, appear in the June edition of Bioengineering & Translational Medicine.
“We looked at groups of children with ASD independent from our previous study and had similar success. We are able to predict with 88 percent accuracy whether children have autism,” said Juergen Hahn, lead author, systems biologist, professor, head of the Rensselaer Polytechnic Institute Department of Biomedical Engineering, and member of the Rensselaer Center for Biotechnology and Interdisciplinary Studies (CBIS). “This is extremely promising.”
It is estimated that approximately 1.7 percent of all children are diagnosed with ASD, characterized as “a developmental disability caused by differences in the brain,” according to the Centers for Disease Control and Prevention. Earlier diagnosis is generally acknowledged to lead to better outcomes as children engage in early intervention services, and an ASD diagnosis is possible at 18-24 months of age. However, because diagnosis depends solely on clinical observations, most children are not diagnosed with ASD until after 4 years of age.
Rather than search for a sole indicator of ASD, the approach Hahn developed uses big data techniques to search for patterns in metabolites relevant to two connected cellular pathways (a series of interactions between molecules that control cell function) with suspected links to ASD.
“Juergen’s work in developing a physiological test for autism is an example of how the interdisciplinary life science-engineering interface at Rensselaer brings new perspectives and solutions to improve human health,” said Deepak Vashishth, CBIS director. “This is a great result from the larger emphasis on Alzheimer’s and neurodegenerative diseases at CBIS, where our work joins multiple approaches to develop better diagnostic tools and biomanufacture new therapeutics.”
The initial success in 2017 analyzed data from a group of 149 people, about half of whom had been previously diagnosed with ASD. For each member of the group, Hahn obtained data on 24 metabolites related to the two cellular pathways–the methionine cycle and the transsulfuration pathway. Deliberately omitting data from one individual in the group, Hahn subjected the remaining dataset to advanced analysis techniques and used results to generate a predictive algorithm. The algorithm then made a prediction about the data from the omitted individual. Hahn cross-validated the results, swapping a different individual out of the group and repeating the process for all 149 participants. His method correctly identified 96.1 percent of all typically developing participants and 97.6 percent of the ASD cohort.
The results were impressive and created, said Hahn, a new goal: “Can we replicate this?”
The new study applies Hahn’s approach to an independent dataset. To avoid the lengthy process of gathering new data through clinical trials, Hahn and his team searched for existing datasets that included the metabolites he had analyzed in the original study. The researchers identified appropriate data from three different studies that included a total of 154 children with autism conducted by researchers at the Arkansas Children’s Research Institute. The data included only 22 of the 24 metabolites he used to create the original predictive algorithm, however Hahn determined the available information would be sufficient for the test.
The team used their approach to recreate the predictive algorithm, this time using data of the 22 metabolites from the original group of 149 children. The algorithm was then applied to the new group of 154 children for testing purposes. When the predictive algorithm was applied to each individual, it correctly predicted autism with 88 percent accuracy.
Hahn said the difference between the original accuracy rate and that of the new study can likely be attributed to several factors, the most important being that two of the metabolites were unavailable in the second dataset. Each of the two metabolites had been strong indicators in the previous study.
Overall, the second study validates the original results, and provides insights into several variants on the approach.
“The most meaningful result is the high degree of accuracy we are able to obtain using this approach on data collected years apart from the original dataset,” said Hahn. “This is an approach that we would like to see move forward into clinical trials and ultimately into a commercially available test.”
Learn more: Success of blood test for autism affirmed
The Latest on: Test for autism
[google_news title=”” keyword=”test for autism” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Test for autism
- Kids With Autism Face Higher Odds of Vision Issues, But Many Don't Get Screenedon March 24, 2023 at 4:31 am
MONDAY, March 27, 2023 (HealthDay News) -- Children with autism are less likely than their peers to receive important vision screening despite a high risk for serious eye disorders, researchers report ...
- 'Public health crisis': Autism rates rise again, with 1 in 36 children diagnosedon March 23, 2023 at 6:09 pm
Autism rates rose again between 2018 and 2020, the most recent year data is available, up from 1 in 44 children to 1 in 36. Many factors are likely to contribute to these rising rates, ...
- CDC report finds more children in U.S. diagnosed with autism due to better screeningon March 23, 2023 at 4:30 pm
In 2020, about 1 in 36 children had been diagnosed with autism by age 8, the CDC says. That's up from 1 in 150 children in 2000.
- Autism now diagnosed more often among Black, Hispanic kids, CDC sayson March 23, 2023 at 4:24 pm
The new estimates suggest that about 3% of Black, Hispanic and Asian or Pacific Islander children have an autism diagnosis, compared with about 2% of white kids.
- Why more children are being diagnosed with autism and what it means for their familieson March 23, 2023 at 3:45 pm
New CDC data revealed an increase in the prevalence of autism spectrum disorder in the U.S. The report shows in 2020, one out of every 36 children in America was diagnosed with autism. In 2018, that ...
- Diagnosis of autism spectrum disorder is on the rise in children, but it's not necessarily bad newson March 23, 2023 at 2:51 pm
A growing number of children in the United States are being diagnosed with autism spectrum disorder according to a report released Thursday by the Centers for Disease Control and Prevention. Overall, ...
- Autism now more common among Black, Hispanic kids in USon March 23, 2023 at 2:11 pm
Among all U.S. 8-year-olds, 1 in 36 had autism in 2020, the CDC estimated. That's up from 1 in 44 two years earlier. But the rate rose faster for children of color than for white kids. The new ...
- Autism Prevalence Rises Again, Study Findson March 23, 2023 at 10:58 am
The pandemic may have disrupted the detection of autism spectrum disorder in young children, researchers also reported.
- Autism diagnosis has become more common, but pandemic disrupted early detection, CDC sayson March 23, 2023 at 10:22 am
The rate of children diagnosed with autism in the United States has been growing steadily since 2000, but two new reports from the US Centers for Disease Control and Prevention highlight disparities ...
via Bing News